Arvee Laboratories (India) Ltd. Hits Upper Circuit on NSE, 28 October 2026

The day started flat for Arvee Laboratories (India) Ltd. and the stock was at its ceiling by the time of capture. On 28 October 2026 the stock opened at Rs 178, a shade under the previous close of Rs 178.58, and was at the Arvee Laboratories (India) upper circuit of Rs 187.5 on NSE when the data was captured, up 4.99%. Anyone who held it through the open now has the gain, and a new buyer has a queue to join. Market cap: Rs 196.8 crore.

Key Takeaways

• Arvee Laboratories (India) Ltd. (ARVEE) hit the upper circuit on NSE at Rs 187.5 on 28 October 2026.
• The session move was +4.99% against a previous close of Rs 178.58.
• Market capitalisation stood at Rs 196.8 crore with a PE ratio of 48.62.
• No official company announcement or verified catalyst was confirmed at the time of writing.
• A price band is an exchange trading rule, not a view on the company or a recommendation.

Key Market Data

Metric	Value
Stock	Arvee Laboratories (India) Ltd.
Current Price / LTP	Rs 187.5
Day Move	4.99%
Previous Close	Rs 178.58
Day Open	Rs 178
Day High	Rs 187.5
Day Low	Rs 178
Upper Circuit Price	Rs 187.5
Upper Circuit Limit	Rs 187.5
Market Cap	Rs 196.8 crore
Selected Exchange	NSE
PE Ratio	48.62

All figures above are as of 28 October 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.

Price Action and Trading Activity

Arvee Laboratories (India) Ltd. opened at Rs 178 on NSE, which was also the lowest price of the day, and then travelled up to Rs 187.5, the top of the range and the band limit. From the earlier close of Rs 178.58, that adds Rs 8.92 to the price, a rise of 4.99%.

Each exchange carries its own band, range and previous close, so everything quoted here is from NSE. Rs 187.5 was the ceiling for the session, and the stock was sitting on it at capture.

Why Arvee Laboratories (India) Ltd. Hit Upper Circuit

Demand overran supply in Arvee Laboratories (India) Ltd. and the price ran to the edge of its exchange band, where the upper circuit stopped it. The company had put out nothing official and no outside trigger had been verified at the time of writing, so only the tape and sentiment are available to explain the move.

The record does not tie earnings, a corporate action, sector news or rumours to it, so none is claimed. Something confirmed later would get its own update.

What the Arvee Laboratories (India) Upper Circuit Means

A stock cannot trade above its upper circuit in a session, and for Arvee Laboratories (India) Ltd. that limit was Rs 187.5 on 28 October 2026.

Exchanges set limits like this to soften sudden jumps and keep the market in order. It describes the session just gone and does not speak to returns after it. The figure is a fact about the session, not a forecast.

Arvee Laboratories (India) Ltd. Fundamentals and Valuation

Arvee Laboratories (India) Ltd. earns Rs 3.67 per share on book value of Rs 32.2. That gives a PE ratio of 48.62 and a PB ratio of 5.55, and the market cap is Rs 196.8 crore. These are reported indicators, not a buy, sell or hold view.

At 5.55 times book, the shares are priced as a multiple of net worth per share. Hopes for growth, asset quality or thin trading in a small counter could each be part of it, and the numbers cannot separate them. The business is in chemicals.

One session at the band is a price event first, and valuation and returns are a separate review.

Peer and Sector Context

Arvee Laboratories (India) Ltd. belongs to the Chemicals industry. The peer table below uses available companies from the same sector or industry to give broader valuation context.

Peer Company	Market Cap	PE	PB	ROE
JUBILANT AGRI N CON PRO L	Rs 2949.43 crore	22.72	5.97	33.4%
Bhansali Engineering Polymers Ltd.	Rs 2752.37 crore	12.4	2.37	17.28%
Nocil Ltd.	Rs 2419.36 crore	36.58	1.35	3.16%
Rossari Biotech Ltd.	Rs 2263.68 crore	14.82	1.61	11.88%
JG Chemicals Ltd.	Rs 2207.74 crore	29.36	3.98	13.82%

Several of these peers are far larger by market capitalisation than Arvee Laboratories (India) Ltd. Size differences change liquidity and cost of capital, so the table is sector context rather than a like-for-like ranking.

Arvee Laboratories (India) Ltd.'s PE ratio was 48.62, compared with an available peer PE average of 23.18, calculated from the 5 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.

Technical Snapshot

The technical snapshot adds context: RSI was 40.78.

Worth flagging: the RSI reading sits on the opposite side of neutral to the day move. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.

What Readers Should Know

On the confirmed side, Arvee Laboratories (India) Ltd. reached its NSE band at Rs 187.5 on 28 October 2026, gaining 4.99% on the day. No official catalyst is on record.

Getting a trade done is the new buyer's problem: bids crowd the ceiling and offers are scarce, so a quote may never turn into a fill.

Read this as a market update only. What the business is worth, how liquid the stock is, what risks it carries and what the company has disclosed are all open and need their own checks.

Frequently Asked Questions

Why did Arvee Laboratories (India) Ltd. hit upper circuit on 28 October 2026?

The stock reached its upper price band after buying interest during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.

What was ARVEE share price on 28 October 2026?

The last traded price used in this article was Rs 187.5 on NSE. That price matched the upper circuit price captured for the event.

What was the upper circuit price for ARVEE?

The upper circuit price was Rs 187.5. The stated exchange upper circuit limit was Rs 187.5. The event numbers in this article are aligned to NSE.

What is Arvee Laboratories (India) Ltd.'s market cap and PE ratio?

Arvee Laboratories (India) Ltd.'s market cap was Rs 196.8 crore. PE ratio was 48.62.

Which exchange and data source were used?

The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 28 October 2026.

Does hitting an upper circuit mean Arvee Laboratories (India) Ltd. is a buy or a sell?

No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.

Can you buy or sell Arvee Laboratories (India) Ltd. shares when the stock is at the upper circuit?

It is usually difficult. At the upper circuit, buy orders queue up while sellers step back, so there may be no counterparty at the quoted price. Orders can stay unfilled until the band opens up or sellers return.

What happens the next trading session after an upper circuit?

There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.

What is the upper circuit limit set at for Indian stocks?

Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Arvee Laboratories (India) Ltd. the stated limit was Rs 187.5. For this session, Arvee Laboratories (India) Ltd. moved 4.99%.